The impact of providing rapid diagnostic malaria tests on fever management in the private retail sector in Ghana: a cluster randomized trial

BMJ : British Medical Journal
Evelyn AnsahChristopher J M Whitty

Abstract

To examine the impact of providing rapid diagnostic tests for malaria on fever management in private drug retail shops where most poor rural people with fever present, with the aim of reducing current massive overdiagnosis and overtreatment of malaria. Cluster randomized trial of 24 clusters of shops. Dangme West, a poor rural district of Ghana. Shops and their clients, both adults and children. Providing rapid diagnostic tests with realistic training. The primary outcome was the proportion of clients testing negative for malaria by a double-read research blood slide who received an artemisinin combination therapy or other antimalarial. Secondary outcomes were use of antibiotics and antipyretics, and safety. Of 4603 clients, 3424 (74.4%) tested negative by double-read research slides. The proportion of slide-negative clients who received any antimalarial was 590/1854 (32%) in the intervention arm and 1378/1570 (88%) in the control arm (adjusted risk ratio 0.41 (95% CI 0.29 to 0.58), P<0.0001). Treatment was in high agreement with rapid diagnostic test result. Of those who were slide-positive, 690/787 (87.8%) in the intervention arm and 347/392 (88.5%) in the control arm received an artemisinin combination therapy (adjusted risk...Continue Reading

Citations

Feb 18, 2016·Emerging Infectious Diseases·Alyssa S ParpiaAlison P Galvani
Dec 17, 2015·Bulletin of the World Health Organization·Theodoor VisserPrashant Yadav
May 20, 2015·Lancet·James D Shelton
Aug 12, 2016·Journal of Research in Pharmacy Practice·Rauf AuduKwame Ohene Buabeng
May 20, 2017·Malaria Journal·UNKNOWN ACTwatch GroupSigsbert Patila Mkunde
May 20, 2017·BMC Public Health·Matthew R Boyce, Wendy P O'Meara
Aug 12, 2016·The Cochrane Database of Systematic Reviews·Charles S WiysongeGregory D Hussey
Aug 19, 2017·The American Journal of Tropical Medicine and Hygiene·Katia J BruxvoortHeidi Hopkins
May 8, 2019·Tropical Doctor·Ashok K Pannu
Jan 24, 2020·The American Journal of Tropical Medicine and Hygiene·Anthony K MbonyePhilip LaRussa
Apr 18, 2018·BMJ Global Health·Brian GreenwoodDavid Schellenberg
May 28, 2020·International Journal of Clinical Pharmacy·Qamar NiazDan Kibuule
Jun 18, 2017·Annals of Global Health·Enrique M SaldarriagaPatricia J Garcia
Dec 20, 2018·Journal of Pharmaceutical Policy and Practice·Samuel Afari-AsieduHeiman Wertheim
Oct 15, 2018·International Journal of Health Policy and Management·Benjamin Sunday C UzochukwuObinna E Onwujekwe

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01907672

Software Mentioned

STATA
Epidata
R

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.